Terms: = Endocrine gland cancer AND PTPRB, ENSG00000127329, 5787, MGC142023, DKFZp686H15164, MGC59935, PTPB, HPTP-BETA, P23467, HPTPB, R-PTP-BETA, FLJ44133, DKFZp686E2262
6 results:
1. PSMD11, PTPRM and ptprb as novel biomarkers of pancreatic cancer progression.
Sahni S; Krisp C; Molloy MP; Nahm C; Maloney S; Gillson J; Gill AJ; Samra J; Mittal A
Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129682. PubMed ID: 32663515
[TBL] [Abstract] [Full Text] [Related]
2. Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.
Shuwen H; Xi Y; Miao D; Jiamin X; Jing Z; Weili G
Dis Markers; 2020; 2020():9369341. PubMed ID: 32626543
[TBL] [Abstract] [Full Text] [Related]
3. Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian cancer.
Basal E; Ayeni T; Zhang Q; Langstraat C; Donahoe PK; Pepin D; Yin X; Leof E; Cliby W
Curr Mol Med; 2016; 16(3):222-31. PubMed ID: 26917267
[TBL] [Abstract] [Full Text] [Related]
4. Radio-frequency ablation of solitary adrenal gland metastasis from renal cell carcinoma.
Mouracade P; Dettloff H; Schneider M; Debras B; Jung JL
Urology; 2009 Dec; 74(6):1341-3. PubMed ID: 19781749
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of resection of the papilla of Vater for the treatment of cancer in the papilla of Vater.
Kinoshita H; Hara M; Nishimura K; Kodama T; Matsuo H; Kawahara R; Yasunaga M; Sakai H; Odo M; Okuda K; Shirouzu K; Aoyagi S
Kurume Med J; 2003; 50(1-2):17-9. PubMed ID: 12971258
[TBL] [Abstract] [Full Text] [Related]
6. A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma.
Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
Eur J Gynaecol Oncol; 1990; 11(2):127-33. PubMed ID: 2379512
[TBL] [Abstract] [Full Text] [Related]
